How Has The Electronic Drug Delivery Systems Market Size Evolved In Recent Years?
The electronic drug delivery systems market has seen considerable growth due to a variety of factors.
•The market size for electronic drug delivery systems has seen considerable expansion in the past few years. The growth is expected to continue, increasing from $11.15 billion in 2024 to $12.02 billion in 2025, which signifies a compound annual growth rate (CAGR) of 7.8%.
The escalation in the historical era is tied to the increasing occurrence of chronic diseases, an aging population, preference for non-invasive treatment among patients, managing healthcare expenses, advancements in clinical aspects, and validation.
What Is The Projected Growth Of The Electronic Drug Delivery Systems Market?
The electronic drug delivery systems market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for electronic drug delivery systems is set for rapid expansion in the coming years, with projections estimating a rise to $17.74 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 10.2%.
This projected growth within the forecasted period can be attributed to a variety of factors such as the advancement in drug personalization, global increase in healthcare expenditure, a more patient-focused approach to healthcare, the rise of targeted therapies, a supportive regulatory framework, and advancement in remote patient monitoring technologies. Key trends expected to be observed within this period encompass the integration of Artificial Intelligence (AI), the utilization of biocompatible materials and implantable devices, customization adapted to specific therapeutic areas, regulatory progress and standardization, as well as partnerships formed between pharmaceutical and tech companies.
What Are The Key Drivers Fueling Growth In The Electronic Drug Delivery Systems Market?
The anticipated growth of the electronic drug delivery systems market can be attributed to the increasing occurrence of chronic diseases. A chronic disease is a long-term condition that persists for over a year and necessitates continual medical intervention. Electronic drug delivery systems are utilized to manage drug dosage and simplify dosage tracking for individuals dealing with chronic conditions. For example, data from the National Library of Medicine, a US agency, in January 2023, projected that the populace in the US above 50 years of age with at least one chronic condition would rise to 142.66 million by 2050. Hence, as chronic diseases become more rampant, they will act as a major driving factor for the growth of the electronic drug delivery system market.
What Are The Principal Market Segments In The Global Electronic Drug Delivery Systems Industry?
The electronic drug delivery systems market covered in this report is segmented –
1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules, Other Types
2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
3) By System Type: Battery-Powered Systems, Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
Subsegments:
1) By Electronic Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
2) By Electronic Injection Pens: Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
4) By Electronic Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
5) By Electronic Capsules: Smart Capsules, Digital Capsules With Sensors
6) By Other Types: Transdermal Drug Delivery Systems, Implantable Drug Delivery Systems, Wearable Drug Delivery Systems
Pre-Book The Electronic Drug Delivery Systems Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Electronic Drug Delivery Systems Sector?
One significant trend in the electronic drug delivery system market is the development and use of advanced, minimally invasive drug delivery technologies. Key players in this market are introducing cutting-edge, innovative drug delivery systems to maintain their market dominance. For example, in March 2022, Germany's specialty chemicals firm, Evonik Industries AG, introduced EUDRATEC SoluFlow, a novel microparticle technology designed to improve the solubility of active ingredients in oral medications. This groundbreaking technology, aimed at treating conditions like cancer, cardiovascular diseases, infectious diseases, and diabetes, reinforces the company's portfolio of oral drug delivery solutions.
Who Are the Key Players in the Electronic Drug Delivery Systems Market?
Major companies operating in the electronic drug delivery systems market include:
• Gerresheimer AG
• Medtronic plc
• Novo Nordisk A/S
• Insulet Corporation
• Bayer AG
• Tandem Diabetes Care
• United Therapeutics Corporation
• F. Hoffmann-La Roche AG
• Elcam Medical
• Sanofi S.A.
• Canè SpA
• FindAir
• Johnson & Johnson Services Inc.
• Antares Pharma Inc
• Abbott Laboratories
• Adherium Ltd.
• H&T Presspart Manufacturing Ltd.
• HCmed Innovations Co. Ltd.
• Amiko Digital Health Limited
• CeQur Corporation
• West Pharmaceutical Services Inc.
• BIOCORP
What are the Regional Insights into the Electronic Drug Delivery Systems Market?
North America was the largest region in the electronic drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
